Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization.

MLA

Azoulay, David, and Netanel A. Horowitz. “Brain‐derived Neurotrophic Factor as a Potential Biomarker of Chemotherapy‐induced Peripheral Neuropathy and Prognosis in Haematological Malignancies; What We Have Learned, the Challenges and a Need for Global Standardization.” British Journal of Haematology, vol. 191, no. 1, Oct. 2020, pp. 17–18. EBSCOhost, https://doi.org/10.1111/bjh.16893.

APA

Azoulay, D., & Horowitz, N. A. (2020). Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization. British Journal of Haematology, 191(1), 17–18. https://doi.org/10.1111/bjh.16893

Chicago

Azoulay, David, and Netanel A. Horowitz. 2020. “Brain‐derived Neurotrophic Factor as a Potential Biomarker of Chemotherapy‐induced Peripheral Neuropathy and Prognosis in Haematological Malignancies; What We Have Learned, the Challenges and a Need for Global Standardization.” British Journal of Haematology 191 (1): 17–18. doi:10.1111/bjh.16893.